In the Margins
Horizons ETF Management's new Medical Marijuana Life Sciences ETF has traded higher in each of its first four sessions. On Monday, the exchange-traded fund—the market's first marijuana-themed ETF—surged 9.9%, bringing its total rise to 17.8%. Read the original story from MarketWatch.
Most Read
Average compensation among mutual fund independent directors was higher in 2024, when compared to the year prior, an increase that was more than double what their ...
Comprehensive guidance on the oversight of sub-advisers that exists in the market has served mutual fund boards well for over 15 years. These frameworks remain foundational, ...
Independent directors who anticipate overseeing exchange-traded fund share classes are contemplating myriad issues related to what many industry participants believe will be a seismic shift in ...
Over the past several weeks, I have written articles exploring conflicts of interest that could challenge a variety of financial industry participants. Those articles explored potential ...